RNADIAGON

Excellence in research and development

of non-coding RNA DIAGnostics in ONcology


is establishing a strong academic-industrial consortium focused on research and development in the field of non-coding RNA diagnostics in oncology

enables the development of personal skills and knowledge of early-stage and experienced researchers from Europe through their long-term stays at the US research center of excellence, and traineeships at the education center and manufacturing facilities of an industrial partner

is increasing the scientific excellence and quality of related research in the participating EU research institutions

enables the dissemination of new technologies and approaches related to this field among other EU research institutions and interested public


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 824036.
Disclaimer: This website and included materials reflect only the author’s view and the Research Executive Agency is not responsible for any use that may be made of the information it contains.